Premium
PROGRESSION FREE SURVIVAL AT 12 MONTHS AFTER FIRST‐LINE THERAPY IS ASSOCIATED WITH FAVOURABLE OUTCOMES AFTER FIRST RELAPSE/PROGRESSION IN PERIPHERAL T‐CELL LYMPHOMA
Author(s) -
Shirouchi Y.,
Yokoyama M.,
Fukuta T.,
Nishihara A.,
Inoue N.,
Uryu H.,
Kusano Y.,
Nishimura N.,
Mishima Y.,
Tsuyama N.,
Takeuchi K.,
Terui Y.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.148_2631
Subject(s) - medicine , peripheral t cell lymphoma , progression free survival , proportional hazards model , oncology , hazard ratio , anaplastic large cell lymphoma , univariate analysis , lymphoma , survival analysis , b symptoms , chemotherapy , multivariate analysis , t cell , immunology , confidence interval , immune system
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom